International: Page 5

Curaleaf Acquisition Marks 1st Step Into Australasian Markets

The company’s deal with Northern Green Canada will also bolster its European flower supply in Germany, Poland and the United Kingdom.

Village Farms International Reports Q4 and 2023 Financials: Record Consolidated Sales for Q4

The produce supplier and owner of Canadian subsidiary Pure Sunfarms cannabis business and U.S.-based Balanced Health Botanicals CBD brand closed the year with positive adjusted EBIDTA on its core businesses, and started buildout of its first production facility in the Netherlands.

Tilray Provides Update on Milestone German Cannabis Legalization

Germany now offers a path to new opportunities for the company in a potential $3 billion medical market.

Germany’s Federal Lawmakers Vote to Legalize Adult-Use Cannabis

The legislation paves way for public possession and personal cultivation at cannabis clubs and at home starting this year.

Jamaica Company Ships 1st Legal Exports of THC to United States For DEA Testing

Pure Jamaican elevates Jamaica as a global provider of legal cannabis with pharmaceutical THC product exports to the U.S. and Brazil.

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

Ukraine Legalizes Medical Cannabis During Wartime

The legislation, passed by Ukraine’s parliament in December, was signed into law by President Volodymyr Zelensky this week.

InterCure Provides Update Regarding Nir Oz Facility in Israel

The company has begun the process of restoring the Southern Israel site.

Thailand to Reverse Cannabis Decriminalization With Ban on Adult Use

Health Minister Chonlanan Srikaew recommended a draft bill that would maintain the country’s medical cannabis law but ban adult use to crack down on a largely unregulated market.

Aurora Cannabis Acquires MedReleaf Australia

MedReleaf Australia holds the No. 2 position in medical cannabis within the rapidly growing ~AUD$400 million Australian market.

Highest-THC Cannabis Doesn’t Mean Highest Price in Foreign Countries

In Australia, Germany, Israel and the United Kingdom, low-THC, mid-low-THC or mid-THC medical oil products command higher prices than high-THC products. Plus, how do U.S. flower product prices compare to those overseas?

Curaleaf International Acquires Can4Med, Expanding Presence in Poland's Growing Medical Cannabis Market

Curaleaf International, through its subsidiary Four 20 Pharma GmbH, is one of the only licensed producers in the Polish market.

Previous Page

Page 5 of 64

Next Page